関連する実験動画
Updated: Jul 8, 2026

06:37
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
拡張性心筋症は,コラーゲン型I/III比の有意な変化と関連しています
M Pauschinger1, D Knopf, S Petschauer
1Medical Clinic II, University Hospital Benjamin Franklin, Freie Universität Berlin, Germany.
Circulation
|June 3, 1999
まとめ
拡張性心筋病 (DCM) は,コラーゲンI型とIII型が増加し,コラーゲンI型とIII型の比率が高くなります. この変化した比率は,DCM患者におけるシストリックおよびダイアストリック機能不全に寄与する可能性があります.
科学分野:
- 心臓病学 心臓病学
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
背景:
- 心筋線維症は,末期拡張性心筋病 (DCM) の特徴である.
- DCMに関連した線維症におけるI型/III型 (Col I/Col III) コラーゲン比の変化の役割は,依然として論争の的となっている.
研究 の 目的:
- DCM患者の心筋コラーゲンタイプI/III比を調査する.
- コラーゲン発現と左心室噴出分数 (EF) の関係を評価する.
主な方法:
- Col I,Col III,TGF-β1およびTGF-β2の遺伝子発現のための定量的競争逆転写酵素-ポリメラーゼ連鎖反応 (qRT-PCR).
- ピクロシリウスの赤色染色,免疫ヒストロ学的染色,およびコラーゲンの定量化のためのヒドロキシプロリン測定法.
- DCM患者 (EF <50%) と対照群 (EF >50%) のエンドミオカルディアル生検の分析.
主要な成果:
- DCMの患者は,Col I mRNAの2倍から6倍,タンパク質のレベルはコントロールと比較して1.6倍増加した.
- コルIII mRNAの濃度がDCM患者で2.0倍増加した.
- コールI/コールIIImRNA比は,DCM患者 (8.2) と対照群 (6.4) の間で有意に高かった.
- DCM患者では,総コラーゲン含有量とヒドロキシプロリン/総タンパク質比率が上昇した.
- DCM患者では,TGF-β1およびTGF-β2の心筋筋mRNA濃度の上昇が観察されました.
結論:
- Col IとCol IIIの発現の差異的な増加は,DCM心筋におけるCol I/Col III比率が上昇する.
- コールI/コールIII比の増加は,コールIの硬さが強くなっているため,DCMにおけるシストリックおよびダイアストリック機能不全に寄与する可能性があります.
さらに関連する動画
関連する概念動画
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

